261Y000239 - Acquisition of Various Medicines - 671/2023

This tender, identified by reference number 261Y000239 and associated with tender number 671/2023, concerns the procurement of a diverse range of pharmaceutical products. The objective is to acquire various medicines to meet the needs of the procuring entity. While specific details regarding the exact list of medicines, quantities, and delivery schedules are not provided in this summary, the tender clearly indicates a requirement for the supply of pharmaceutical goods. Potential bidders are expected to be suppliers or manufacturers capable of providing the specified medications. The tender falls within the healthcare sector, specifically focusing on pharmaceutical supply chain management. Further details regarding eligibility criteria, technical specifications for the medicines, submission deadlines, and evaluation procedures are likely available in the full tender documentation. This procurement process aims to ensure the availability of essential medicines, contributing to public health services. Interested parties should consult the official tender documents for comprehensive information and to prepare their proposals accordingly. The scope of work involves the supply of these medicines, potentially including logistics and quality assurance aspects, depending on the detailed requirements outlined in the tender package.

This is a supplies contract in the health and medical services, transport and logistics and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 53,485.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.